Project Description

ClearPath Diagnostics

ClearPath_port500x300

In October 2016 Shore announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company. Together, Shore Capital and ClearPath executed a growth strategy that extended the company’s geographic reach to four states and expanded the service menu to include new cutting-edge tests. The growth was driven by organic initiatives as ClearPath expanded the sales force from one professional to a team of nine highly trained business development experts and implemented LEAN processes that ensured best-in-class turnaround times.

Headquarters

Syracuse, NY

Sector

Laboratory Services

With Shore Since

September 2011

Exited

October 2016

Independent Board Members

Robert DeCresce
James Forrest
Michael George
Kevin Johnson

Key Shore Contact

John Hennegan